Erythropoietin and the Nervous System : Novel Therapeutic Options for Neuroprotection /
Contributor(s): Höke, Ahmet [editor.] | SpringerLink (Online service).
Material type:
BookPublisher: Boston, MA : Springer US, 2006.Description: XI, 223 p. online resource.Content type: text Media type: computer Carrier type: online resourceISBN: 9780387300115.Subject(s): Medicine | Neurosciences | Neurology | Neurosurgery | Psychiatry | Medicine & Public Health | Neurology | Neurosciences | Psychiatry | NeurosurgeryDDC classification: 616.8 Online resources: Click here to access online | Item type | Current location | Call number | Status | Date due | Barcode | Item holds |
|---|---|---|---|---|---|---|
E books
|
PK Kelkar Library, IIT Kanpur | Available | EBK2042 |
History and Biology of Erythropoietin in Hematopoietic and Non-Neural Tissues -- Expression of Erythropoietin and Its Receptor in the Central Nervous System -- Erythropoietin and Neuroprotection in the Central Nervous System: Intracellular Signaling Pathways -- Regulation of Erythropoietin Expression in the Nervous System: The Hypoxia Inducible Factor -- Erythropoietin Neuroprotection in the Term and Preterm Infant: Safety and Efficacy -- Erythropoietin for the Treatment of Acute Ischemic Stroke: Preclinical Rationale -- Erythropoietin Neuroprotection in the Retina -- Erythropoietin for Treatment of Human Brain Disease: Experience from Proof-of-Concept Trials -- Erythropoietin in Spinal Cord Injury -- Erythropoietin and Neuroprotection in the Peripheral Nervous System: In Vivo Studies -- An Endogenous Pathway Preventing Axonal Degeneration Mediated by Schwann Cell — Derived Erythropoietin -- Role of Erythropoietin in Inflammatory Pathologies of the CNS -- Development of Non-Erythropoietic Erythropoietin Variants for Neuroprotection.
Erythropoietin and the Nervous System is the first book of its kind to bring together researchers from many different disciplines of neuroscience to present a current state-of-the-art review of multiple aspects of erythropoietin research as it relates to the nervous system. Erythropoietin (EPO) is a chemokine hormone that is widely distributed throughout the body. In addition to its traditional role as a hormone that stimulates red blood cell production, in recent years many laboratories have shown that EPO can act as a neuroprotective compound in a variety of injury paradigms in the nervous system. Past experience with the relatively safety profile of this FDA-approved drug makes it an ideal candidate to take into clinical trials for neuroprotection. We are on the verge of major clinical trials using this drug for neuroprotection in diseases ranging from stroke, to transverse myelitis to chemotherapy-induced peripheral neuropathy. This book should stimulate new research on erythropoietin and the nervous system and bring new investigators to the field. It will benefit scientists and clinicians interested in neuroprotection in the broadest sense.
There are no comments for this item.